Ontology highlight
ABSTRACT: Background
Infection with human cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid organ and hematopoietic stem cell transplant (HSCT) recipients.Methods
The present study explored the safety, feasibility, and immunogenicity of CMV pp65 messenger RNA-loaded autologous monocyte-derived dendritic cells (DC) as a cellular vaccine for active immunization in healthy volunteers and allogeneic HSCT recipients. Four CMV-seronegative healthy volunteers and three allogeneic HSCT recipients were included in the study. Four clinical-grade autologous monocyte-derived DC vaccines were prepared after a single leukapheresis procedure and administered intradermally at a weekly interval.Results
De novo induction of CMV-specific T-cell responses was detec
SUBMITTER: Van Craenenbroeck AH
PROVIDER: S-EPMC4281162 | biostudies-literature | 2015 Jan
REPOSITORIES: biostudies-literature